During the pandemic, physicians used infusions of monoclonal antibodies—antibodies made in a lab—to help patients fight off COVID-19 infections. Now, researchers at UC Davis are trying to create monoclonal antibodies that can help fight chronic pain. The goal is to develop a monthly non-addictive pain medication that can replace opioids.